[GAMUDA] QoQ Annualized Quarter Result on 31-Jul-2023 [#4]

Announcement Date
27-Sep-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Jul-2023
Quarter
31-Jul-2023 [#4]
Profit Trend
QoQ- -13.1%
YoY- 128.03%
View:
Show?
Annualized Quarter Result
30/04/24 31/01/24 31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 CAGR
Revenue 11,500,708 12,270,900 11,218,604 8,233,552 6,422,308 5,499,294 5,226,480 69.25%
PBT 997,646 958,708 958,920 1,067,575 965,704 829,640 738,832 22.18%
Tax -116,930 -122,580 -151,436 937,485 1,369,664 2,218,358 4,561,376 -
NP 880,716 836,128 807,484 2,005,060 2,335,368 3,047,998 5,300,208 -69.80%
-
NP to SH 852,853 807,688 780,168 1,838,401 2,115,537 2,726,574 4,674,672 -67.86%
-
Tax Rate 11.72% 12.79% 15.79% -87.81% -141.83% -267.39% -617.38% -
Total Cost 10,619,992 11,434,772 10,411,120 6,228,492 4,086,940 2,451,296 -73,728 -
-
Net Worth 11,570,586 11,486,538 11,122,490 10,807,049 10,689,469 10,122,955 11,139,941 2.56%
Dividend
30/04/24 31/01/24 31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 CAGR
Div 590,524 327,407 644,782 1,330,917 1,772,714 2,295,927 4,538,494 -74.35%
Div Payout % 69.24% 40.54% 82.65% 72.40% 83.80% 84.21% 97.09% -
Equity
30/04/24 31/01/24 31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 CAGR
Net Worth 11,570,586 11,486,538 11,122,490 10,807,049 10,689,469 10,122,955 11,139,941 2.56%
NOSH 2,769,642 2,734,601 2,698,138 2,662,493 2,659,570 2,617,909 2,591,069 4.54%
Ratio Analysis
30/04/24 31/01/24 31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 CAGR
NP Margin 7.66% 6.81% 7.20% 24.35% 36.36% 55.43% 101.41% -
ROE 7.37% 7.03% 7.01% 17.01% 19.79% 26.93% 41.96% -
Per Share
30/04/24 31/01/24 31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 CAGR
RPS 415.48 449.75 417.58 309.32 241.52 210.78 202.68 61.44%
EPS 31.27 29.84 29.04 69.93 80.80 105.12 181.28 -69.04%
DPS 21.33 12.00 24.00 50.00 66.67 88.00 176.00 -75.54%
NAPS 4.18 4.21 4.14 4.06 4.02 3.88 4.32 -2.17%
Adjusted Per Share Value based on latest NOSH - 2,662,493
30/04/24 31/01/24 31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 CAGR
RPS 407.59 434.88 397.59 291.80 227.61 194.89 185.23 69.25%
EPS 30.23 28.62 27.65 65.15 74.97 96.63 165.67 -67.86%
DPS 20.93 11.60 22.85 47.17 62.83 81.37 160.84 -74.35%
NAPS 4.1006 4.0708 3.9418 3.83 3.7883 3.5876 3.948 2.56%
Price Multiplier on Financial Quarter End Date
30/04/24 31/01/24 31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 CAGR
Date 30/04/24 31/01/24 31/10/23 31/07/23 28/04/23 31/01/23 31/10/22 -
Price 5.31 5.05 4.64 4.30 4.15 3.92 3.85 -
P/RPS 1.28 1.12 1.11 1.39 1.72 1.86 1.90 -23.16%
P/EPS 17.23 17.06 15.98 6.23 5.22 3.75 2.12 304.75%
EY 5.80 5.86 6.26 16.06 19.17 26.66 47.09 -75.27%
DY 4.02 2.38 5.17 11.63 16.06 22.45 45.71 -80.25%
P/NAPS 1.27 1.20 1.12 1.06 1.03 1.01 0.89 26.77%
Price Multiplier on Announcement Date
30/04/24 31/01/24 31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 CAGR
Date 25/06/24 27/03/24 06/12/23 27/09/23 22/06/23 23/03/23 16/12/22 -
Price 6.50 5.27 4.41 4.31 4.25 4.14 3.61 -
P/RPS 1.56 1.17 1.06 1.39 1.76 1.96 1.78 -8.42%
P/EPS 21.10 17.80 15.19 6.24 5.34 3.96 1.99 383.33%
EY 4.74 5.62 6.58 16.02 18.72 25.24 50.22 -79.29%
DY 3.28 2.28 5.44 11.60 15.69 21.26 48.75 -83.48%
P/NAPS 1.56 1.25 1.07 1.06 1.06 1.07 0.84 51.14%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment